Nomura Holdings Inc. lifted its position in Cardinal Health Inc (NYSE:CAH) by 43.4% in the 3rd quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 34,453 shares of the company’s stock after acquiring an additional 10,422 shares during the quarter. Nomura Holdings Inc.’s holdings in Cardinal Health were worth $1,629,000 as of its most recent filing with the SEC.

Several other large investors have also recently modified their holdings of CAH. Invesco Ltd. lifted its position in shares of Cardinal Health by 28.5% in the 2nd quarter. Invesco Ltd. now owns 8,150,786 shares of the company’s stock valued at $383,901,000 after acquiring an additional 1,808,381 shares in the last quarter. Nuveen Asset Management LLC lifted its position in shares of Cardinal Health by 236.2% in the 2nd quarter. Nuveen Asset Management LLC now owns 2,044,496 shares of the company’s stock valued at $96,296,000 after acquiring an additional 1,436,412 shares in the last quarter. Macquarie Group Ltd. lifted its position in shares of Cardinal Health by 5.3% in the 2nd quarter. Macquarie Group Ltd. now owns 14,736,537 shares of the company’s stock valued at $694,090,000 after acquiring an additional 742,724 shares in the last quarter. Point72 Asset Management L.P. lifted its position in shares of Cardinal Health by 12,324.4% in the 3rd quarter. Point72 Asset Management L.P. now owns 683,344 shares of the company’s stock valued at $32,247,000 after acquiring an additional 677,844 shares in the last quarter. Finally, State Street Corp lifted its position in shares of Cardinal Health by 3.1% in the 3rd quarter. State Street Corp now owns 21,778,838 shares of the company’s stock valued at $1,038,087,000 after acquiring an additional 650,769 shares in the last quarter. Institutional investors and hedge funds own 88.98% of the company’s stock.

CAH stock opened at $53.66 on Friday. Cardinal Health Inc has a 12-month low of $41.03 and a 12-month high of $56.88. The company has a quick ratio of 0.50, a current ratio of 1.05 and a debt-to-equity ratio of 8.15. The company has a market cap of $15.69 billion, a price-to-earnings ratio of 10.16, a PEG ratio of 1.74 and a beta of 1.34. The company has a 50 day moving average of $53.64 and a two-hundred day moving average of $47.71.

Cardinal Health (NYSE:CAH) last released its earnings results on Thursday, November 7th. The company reported $1.27 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.09 by $0.18. Cardinal Health had a negative net margin of 2.81% and a positive return on equity of 32.25%. The company had revenue of $37.34 billion during the quarter, compared to the consensus estimate of $36.75 billion. During the same quarter in the prior year, the firm earned $1.29 EPS. The company’s revenue was up 6.0% compared to the same quarter last year. On average, research analysts anticipate that Cardinal Health Inc will post 5.05 EPS for the current year.

The business also recently announced a quarterly dividend, which will be paid on Wednesday, January 15th. Shareholders of record on Thursday, January 2nd will be given a $0.481 dividend. The ex-dividend date is Tuesday, December 31st. This represents a $1.92 dividend on an annualized basis and a yield of 3.59%. Cardinal Health’s payout ratio is 36.36%.

Several equities research analysts recently commented on the stock. Guggenheim set a $55.00 price target on shares of Cardinal Health and gave the company a “buy” rating in a research report on Thursday, September 12th. TheStreet downgraded shares of Cardinal Health from a “c+” rating to a “d” rating in a research report on Thursday, November 7th. Morgan Stanley reduced their price target on shares of Cardinal Health from $50.00 to $41.00 and set an “underweight” rating for the company in a research report on Friday, September 6th. Deutsche Bank assumed coverage on shares of Cardinal Health in a research report on Thursday, September 12th. They issued a “hold” rating and a $50.00 price target for the company. Finally, Zacks Investment Research upgraded shares of Cardinal Health from a “hold” rating to a “buy” rating and set a $56.00 price target for the company in a research report on Monday, November 11th. Three research analysts have rated the stock with a sell rating, three have issued a hold rating and two have issued a buy rating to the stock. The stock has an average rating of “Hold” and a consensus price target of $50.60.

About Cardinal Health

Cardinal Health, Inc operates as an integrated healthcare services and products company in the United States and internationally. It provides medical products and pharmaceuticals, and solutions that enhance supply chain efficiency for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, and physician offices.

Read More: Most Active Stocks

Want to see what other hedge funds are holding CAH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cardinal Health Inc (NYSE:CAH).

Institutional Ownership by Quarter for Cardinal Health (NYSE:CAH)

Receive News & Ratings for Cardinal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health and related companies with MarketBeat.com's FREE daily email newsletter.